HK StockDetailed Quotes

Provided by Tiger Fintech (Singapore) Pte. Ltd.

Post-Pandemic Stocks

1,279.786

+11.2120.88%

Number of Gainers:12

Number of Losers:4

Number of Flat:2

PE:- -

High:1,295.991

Open:1,268.170

Low:1,261.383

Close:1,268.574

Volume:532.19M

Turnover:5.11B

Market Cap:861.27B

Float Cap:717.98B

Loading ...

SIHUAN PHARM (00460) Signs Collaboration Agreement with U.S.'s AbaloneBio to Jointly Develop Next-Generation Weight Loss and Muscle-Building Therapy, Further Expanding GPCR Target Portfolio

Ascletis Pharma Reports ASC36 Achieves Superior Weight Loss in Preclinical Obesity Studies

ASCLETIS-B (01672) Selects Best-in-Class Monthly Subcutaneous Amylin Receptor Agonist ASC36 for Clinical Development

Sihuan Pharmaceutical Partners with Abalone Bio to Develop Innovative Weight Loss Therapy

Sihuan Pharma - Co and Abalone to Develop New Obesity Drug

THOMSON REUTERS

CanSino Biologics Inc. Beat Analyst Profit Forecasts, And Analysts Have New Estimates

Simply Wall St.

Zhejiang Couple Amasses $60 Billion Fortune by Selling Trading Cards to Schoolchildren

Zhong Huijuan and Daughter Top China's Richest Women List with $141 Billion Fortune

Breaking Boundaries with AI: FANGZHOU JIANKE (06086) and FOSUN PHARMA (02196) Forge Strategic Partnership to Build a Digital Ecosystem for Psoriasis Management

MIIT Urges Accelerated Breakthroughs in Core Technologies to Strengthen Pharmaceutical Supply Chain Resilience

Richard Liu and Zhang Zetian Spotted Together at Meeting in South Korea

Guoyi Securities Maintains "Buy" Rating on Fosun Pharma (02196) with Target Price of HK$26.5

Chinese Automakers Achieve Best Month in Europe, Market Share Surpasses Korean Rivals for First Time

Jilin Explores New "Group Elderly Care" Model Through Shared Village Communities

CICC Maintains Outperform Rating on SINOPHARM (01099) with Target Price of HK$24.7

Puyin International Maintains "Hold" Rating on PA GOODDOCTOR (01833) with Target Price of HK$14.0

HK Stock Buyback Summary | October 29

BRIEF-Tong Ren Tang Technologies Says 9M Unaudited Net Profits Attributable RMB416.26 Million

BAIYUNSHAN PH (00874) Reports Q3 Results: Net Profit Rises 4.78% YoY to RMB3.31 Billion

ASCLETIS-B (01672) Repurchased 100,000 Shares for HK$918,900 on October 28

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/stock/BK1515/news?page=3"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"BK1515","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"BK1515\",,,,,undefined,":{"symbol":"BK1515","market":"HK","secType":"PLATE","nameCN":"Post-Pandemic Stocks","latestPrice":1279.7856,"timestamp":1761898110601,"preClose":1268.5741,"halted":0,"volume":532188982,"delay":0,"changeRate":0.008838,"floatShares":0,"shares":0,"eps":0,"marketStatus":"Market Closed","change":11.211548,"latestTime":"10-31 16:00:00","open":1268.1698,"high":1295.9907,"low":1261.3832,"amount":5106575720,"amplitude":0.027281,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"tradingStatus":0,"nextMarketStatus":{"tag":"Open","tradingStatus":2,"beginTime":1762133400000},"marketStatusCode":0,"adr":0,"adjPreClose":0,"openAndCloseTimeList":[[1761874200000,1761883200000],[1761886800000,1761897600000]],"pbRate":2.04017,"peRate":26.642351,"turnoverRate":0.006985,"increases":13,"decrements":4,"flats":0,"marketCap":861271445760,"floatMarketCap":717976357248},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"BK1515\",,,,,undefined,":{"symbol":"BK1515","high":1295.9907,"amplitude":0.027281,"preClose":1268.5741,"low":1261.3832,"pbRate":"2.04017","latestPrice":1279.7856,"volume":532188982,"delay":0,"open":1268.1698,"prevYearClose":787.97723,"prevWeekClose":1302.542,"prevMonthClose":1279.786,"prevQuarterClose":1449.838,"fiveDayClose":1307.01,"twentyDayClose":1449.838,"sixtyDayClose":1249.855,"secType":"PLATE","market":"HK","turnoverRate":0.006985,"peRate":26.642351,"marketCap":861271445760,"floatMarketCap":717976357248,"timestamp":1761898110601,"nameCN":"Post-Pandemic Stocks"},"@#url:\"https://hq.skytigris.cn/api/global/plate/up_down\",method:\"POST\",data:#delay:false,bkCodes:@\"BK1515\",,,,undefined,":{"bkCode":"BK1515","up":12,"down":4,"flat":2},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"BK1515\",pageSize:20,pageCount:3,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"1124178700","title":"SIHUAN PHARM (00460) Signs Collaboration Agreement with U.S.'s AbaloneBio to Jointly Develop Next-Generation Weight Loss and Muscle-Building Therapy, Further Expanding GPCR Target Portfolio","url":"https://stock-news.laohu8.com/highlight/detail?id=1124178700","media":"Stock News","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1124178700?lang=en_us&edition=fundamental","pubTime":"2025-10-30 08:14","pubTimestamp":1761783261,"startTime":"0","endTime":"0","summary":"SIHUAN PHARM (00460) announced that the group has formally entered into a collaboration agreement with U.S. biotech firm AbaloneBio (Abalone). Under the agreement, the two parties will collaborate...","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1191","GPCR","00460","BK1593","BK4599","BK4007","BK1600","BK1515"],"gpt_icon":0},{"id":"2579315619","title":"Ascletis Pharma Reports ASC36 Achieves Superior Weight Loss in Preclinical Obesity Studies","url":"https://stock-news.laohu8.com/highlight/detail?id=2579315619","media":"Reuters","labels":["dataReport","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2579315619?lang=en_us&edition=fundamental","pubTime":"2025-10-30 08:10","pubTimestamp":1761783024,"startTime":"0","endTime":"0","summary":"Ascletis Pharma Inc. has announced the selection of ASC36, a once-monthly subcutaneously administered amylin receptor agonist, as a clinical development candidate for the treatment of obesity. In preclinical studies, ASC36 showed an average observed half-life of approximately 15 days in non-human primates, which is three times longer than petrelintide, supporting its potential for once-monthly dosing in humans. Additionally, ASC36 demonstrated approximately 91% greater relative body weight reduction compared to petrelintide in a diet-induced obese rat study. The company expects to submit an Investigational New Drug Application  for ASC36 to the U.S. FDA in the second quarter of 2026. These results and further plans for monotherapy and combination therapies with ASC36 were announced but have not yet been presented at a scientific conference.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251030:nNDLch5r9m:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1515","BK1161","01672","BK1574"],"gpt_icon":0},{"id":"1135533889","title":"ASCLETIS-B (01672) Selects Best-in-Class Monthly Subcutaneous Amylin Receptor Agonist ASC36 for Clinical Development","url":"https://stock-news.laohu8.com/highlight/detail?id=1135533889","media":"Stock News","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1135533889?lang=en_us&edition=fundamental","pubTime":"2025-10-30 08:10","pubTimestamp":1761783013,"startTime":"0","endTime":"0","summary":"ASCLETIS-B (01672) announced the selection of ASC36, a potential best-in-class monthly subcutaneous amylin receptor agonist, as its clinical development candidate. The company plans to submit an...","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["01477","BK1574","BK1515","01672","BK1191","BK1161"],"gpt_icon":0},{"id":"2579156349","title":"Sihuan Pharmaceutical Partners with Abalone Bio to Develop Innovative Weight Loss Therapy","url":"https://stock-news.laohu8.com/highlight/detail?id=2579156349","media":"Reuters","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2579156349?lang=en_us&edition=fundamental","pubTime":"2025-10-30 08:01","pubTimestamp":1761782509,"startTime":"0","endTime":"0","summary":"Sihuan Pharmaceutical Holdings Group Ltd. has announced the signing of a cooperation agreement with U.S.-based biotechnology company Abalone Bio. Under this agreement, the two companies will collaborate globally to jointly develop a new-generation innovative therapy aimed at weight loss and muscle gain, further strengthening Sihuan Pharmaceutical's presence in the GPCR  target field. The partnership reflects the company's ongoing commitment to innovation in the medical aesthetics and biopharmaceutical sectors.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Sihuan Pharmaceutical Holdings Group Ltd. published the original content used to generate this news brief on October 30, 2025, and is solely responsible for the information contained","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251030:nNDL4SrjYz:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["00460","BK1600","BK1515","BK1191","BK1593"],"gpt_icon":0},{"id":"2579315637","title":"Sihuan Pharma - Co and Abalone to Develop New Obesity Drug","url":"https://stock-news.laohu8.com/highlight/detail?id=2579315637","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2579315637?lang=en_us&edition=fundamental","pubTime":"2025-10-30 08:00","pubTimestamp":1761782459,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251030:nFWN3WA2HF:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK1593","BK1191","00460","BK1515","BK1600"],"gpt_icon":0},{"id":"2579845166","title":"CanSino Biologics Inc. Beat Analyst Profit Forecasts, And Analysts Have New Estimates","url":"https://stock-news.laohu8.com/highlight/detail?id=2579845166","media":"Simply Wall St.","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2579845166?lang=en_us&edition=fundamental","pubTime":"2025-10-30 06:23","pubTimestamp":1761776602,"startTime":"0","endTime":"0","summary":"Investors in CanSino Biologics Inc. ( HKG:6185 ) had a good week, as its shares rose 4.1% to close at HK$44.92...","market":"us","thumbnail":"https://images.simplywall.st/asset/industry/6121000-choice2-main-header/1585186699299","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/6121000-choice2-main-header/1585186699299"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/hk/pharmaceuticals-biotech/hkg-6185/cansino-biologics-shares/news/cansino-biologics-inc-beat-analyst-profit-forecasts-and-anal","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/hk/pharmaceuticals-biotech/hkg-6185/cansino-biologics-shares/news/cansino-biologics-inc-beat-analyst-profit-forecasts-and-anal","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["BK1161","BK1191","06185","BK1515","BK1574"],"gpt_icon":0},{"id":"1106533101","title":"Zhejiang Couple Amasses $60 Billion Fortune by Selling Trading Cards to Schoolchildren","url":"https://stock-news.laohu8.com/highlight/detail?id=1106533101","media":"Deep News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1106533101?lang=en_us&edition=fundamental","pubTime":"2025-10-29 20:41","pubTimestamp":1761741704,"startTime":"0","endTime":"0","summary":"A Zhejiang couple has become billionaires by selling trading cards to elementary school students. The recently released 2025 Hurun Rich List revealed Li Qibin and Qi Yan, founders of the trading card...","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU1044874839.SGD","BK1619","LU1023057109.AUD","89618","SG9999002562.SGD","BK1583","BK1571","LU1366334651.USD","BK1142","LU0084288322.USD","LU0307460666.USD","LU1688375341.USD","LU0672654166.SGD","LU0499858438.USD","LU0149721374.USD","LU0594300419.USD","LU1770036033.HKD","IE0008368742.USD","LU0791590937.USD","BK4579","LU0588545490.SGD","LU0868486357.SGD","LU0650527681.SGD","BK4122","LU0315178854.USD","BK4531","LU0259732245.USD","LU0140636845.USD","LU0048580855.USD","LU0871576103.HKD","LU1224444064.USD","LU1481107354.HKD","LU1044875133.USD","SG9999002463.SGD","LU0463099449.HKD","LU0469268626.HKD","LU1880383366.USD","LU0359202008.SGD","LU0588546209.SGD","LU0314109678.HKD","LU1328277881.USD","BK1247","LU1303224171.USD","LU1770034418.SGD","LU1044876610.USD","LU0431992006.USD","06618","LU1282651048.USD","BK4503","LU0456846285.SGD","LU1642822792.SGD","LU0456827905.SGD","LU1808992512.USD","LU0320764599.SGD","HK0000320264.USD","LU0164880469.USD","BK4614","LU0327786744.USD","LU0039217434.USD","BK4504","BK4558","IE00BGV7N243.SGD","LU0417516738.SGD","BK4585","LU0128522157.USD","LU0345775950.USD","HK0000306701.USD","LU0163747925.USD","LU0228367735.SGD","LU0499858602.USD","LU0320764755.SGD","LU0384037296.USD","LU0244354667.USD","LU0588545904.SGD","LU0348805143.USD","BK1615","SGXZ86797644.SGD","LU0106959298.USD","LU2257852520.SGD","LU0588545730.USD","BK1610","BK1589","LU0543330483.HKD","LU1282651121.HKD","BK1575","LU1188198961.HKD","LU1720050803.USD","LU0326950275.SGD","LU0315179316.USD","BK4588","LU0211977185.USD","LU0370786039.SGD","LU0456842615.SGD","LU0359201612.USD","LU0231483743.USD","HK0000306685.HKD","JD","SG9999002828.SGD","LU0051755006.USD","LU2242644610.SGD","SG9999001226.SGD","LU1366334578.USD","BK4551","BK4509","BK1515","LU0791591158.USD","LU0488056044.USD","LU0708995583.HKD","86618","BK1502","LU1813983027.USD","BK4220","HK0000320223.HKD","SGXZ62798434.SGD","LU1282649810.SGD","LU0228659784.USD","LU0029875118.USD","BK4526","LU0293314216.USD","LU0572944931.SGD","LU1251922891.USD","LU1282649067.USD","LU0531971595.HKD","LU1719994722.HKD","BK4505","LU0348825331.USD","LU2039709279.SGD","LU0828237510.HKD","09618","LU1794554557.SGD","IE0032431581.USD","LU0359201885.HKD","BK1588","LU0052750758.USD","LU0164865239.USD","IE00B3M56506.USD","BK4524","IE00B29SXG58.USD","LU0348735423.USD","LU0417516902.SGD","BK1591","BK1249","LU0865486749.SGD","LU0345776255.USD"],"gpt_icon":1},{"id":"1163899812","title":"Zhong Huijuan and Daughter Top China's Richest Women List with $141 Billion Fortune","url":"https://stock-news.laohu8.com/highlight/detail?id=1163899812","media":"Deep News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1163899812?lang=en_us&edition=fundamental","pubTime":"2025-10-29 19:20","pubTimestamp":1761736857,"startTime":"0","endTime":"0","summary":"China's pharmaceutical power couple has reached new heights of wealth. On October 28, 2025, the Hurun Research Institute released its annual rich list, revealing that Zhong Huijuan, Chairwoman and...","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1161","09939","BK1515","BK1574","159938"],"gpt_icon":0},{"id":"1100975095","title":"Breaking Boundaries with AI: FANGZHOU JIANKE (06086) and FOSUN PHARMA (02196) Forge Strategic Partnership to Build a Digital Ecosystem for Psoriasis Management","url":"https://stock-news.laohu8.com/highlight/detail?id=1100975095","media":"Stock News","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1100975095?lang=en_us&edition=fundamental","pubTime":"2025-10-29 18:50","pubTimestamp":1761735050,"startTime":"0","endTime":"0","summary":"On October 29, coinciding with World Psoriasis Day, FANGZHOU JIANKE (06086) and FOSUN PHARMA (02196) held a strategic cooperation signing ceremony in Shanghai. Dr. Xie Fangmin, Founder, Chairman, and...","market":"nz","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK0187","BK0028","02196","BK1593","BK0012","BK0196","BK0183","BK0188","BK0060","BK0239","BK0096","BK1247","BK0175","BK1515","600196","BK1191","06086"],"gpt_icon":0},{"id":"1154851365","title":"MIIT Urges Accelerated Breakthroughs in Core Technologies to Strengthen Pharmaceutical Supply Chain Resilience","url":"https://stock-news.laohu8.com/highlight/detail?id=1154851365","media":"Stock News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1154851365?lang=en_us&edition=fundamental","pubTime":"2025-10-29 18:46","pubTimestamp":1761734805,"startTime":"0","endTime":"0","summary":"On October 28, 2025, the Consumer Goods Industry Department of China's Ministry of Industry and Information Technology (MIIT) convened a symposium in Nanchang, Jiangxi Province, focusing on...","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["09939","BK1161","BK1574","159938","BK1515"],"gpt_icon":0},{"id":"1139737678","title":"Richard Liu and Zhang Zetian Spotted Together at Meeting in South Korea","url":"https://stock-news.laohu8.com/highlight/detail?id=1139737678","media":"Deep News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1139737678?lang=en_us&edition=fundamental","pubTime":"2025-10-29 17:40","pubTimestamp":1761730823,"startTime":"0","endTime":"0","summary":"On October 29, photos surfaced online showing Richard Liu (Liu Qiangdong) and Zhang Zetian attending a meeting together in South Korea. In the images, Liu, dressed in a formal suit, sat beside Zhang,...","market":"sg","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4503","LU0164880469.USD","LU1794554557.SGD","SG9999002463.SGD","LU0314109678.HKD","BK1583","JD","LU0163747925.USD","HK0000320223.HKD","LU0417516902.SGD","LU0320764599.SGD","LU2257852520.SGD","LU0359201612.USD","LU1282649067.USD","LU0791591158.USD","LU0029875118.USD","IE00BGV7N243.SGD","LU1366334578.USD","HK0000320264.USD","LU0211977185.USD","LU0672654166.SGD","LU0348825331.USD","BK1571","LU0370786039.SGD","LU0588545730.USD","LU2039709279.SGD","BK4588","BK4579","BK1610","LU0327786744.USD","LU0469268626.HKD","BK1249","LU0345776255.USD","SG9999001226.SGD","06618","LU0868486357.SGD","BK4504","LU0588546209.SGD","LU1880383366.USD","BK1591","LU0865486749.SGD","LU0708995583.HKD","LU1481107354.HKD","LU0315179316.USD","LU0499858438.USD","LU0307460666.USD","LU0456846285.SGD","LU0543330483.HKD","LU0320764755.SGD","BK1247","BK1619","LU1282651048.USD","LU0259732245.USD","LU0791590937.USD","86618","LU0231483743.USD","LU0572944931.SGD","LU0499858602.USD","BK4509","LU0463099449.HKD","BK4614","LU0140636845.USD","LU0048580855.USD","BK4122","LU0039217434.USD","BK1142","BK4505","LU0417516738.SGD","LU1366334651.USD","SG9999002828.SGD","BK4526","LU0588545490.SGD","89618","LU0828237510.HKD","LU1688375341.USD","LU0456842615.SGD","LU1642822792.SGD","LU1719994722.HKD","BK4531","LU1023057109.AUD","LU1224444064.USD","BK4551","LU0594300419.USD","LU2242644610.SGD","LU0359202008.SGD","LU0084288322.USD","LU0650527681.SGD","LU1044876610.USD","LU0326950275.SGD","IE0008368742.USD","LU0348735423.USD","LU0149721374.USD","LU0164865239.USD","LU0384037296.USD","LU0871576103.HKD","LU1044874839.SGD","LU1770034418.SGD","BK4524","LU1303224171.USD","BK1589","LU0051755006.USD","LU0588545904.SGD","SGXZ62798434.SGD","BK1575","LU0359201885.HKD","IE0032431581.USD","LU1328277881.USD","LU1044875133.USD","HK0000306685.HKD","LU0348805143.USD","SG9999002562.SGD","LU0244354667.USD","BK4585","BK4558","LU1808992512.USD","09618","LU0431992006.USD","LU1188198961.HKD","IE00B29SXG58.USD","BK1588","LU0106959298.USD","BK4220","LU0315178854.USD","LU1282649810.SGD","IE00B3M56506.USD","LU0531971595.HKD","SGXZ86797644.SGD","LU0345775950.USD","LU1770036033.HKD","LU1251922891.USD","LU0052750758.USD","LU1282651121.HKD","LU0293314216.USD","BK1502","LU0228367735.SGD","BK1615","LU1813983027.USD","LU0128522157.USD","LU0228659784.USD","LU1720050803.USD","LU0488056044.USD","LU0456827905.SGD","HK0000306701.USD","BK1515"],"gpt_icon":1},{"id":"1178571530","title":"Guoyi Securities Maintains \"Buy\" Rating on Fosun Pharma (02196) with Target Price of HK$26.5","url":"https://stock-news.laohu8.com/highlight/detail?id=1178571530","media":"Stock News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1178571530?lang=en_us&edition=fundamental","pubTime":"2025-10-29 14:38","pubTimestamp":1761719922,"startTime":"0","endTime":"0","summary":"Guoyi Securities released a research report projecting that Fosun Pharma (02196) will achieve net profits of RMB3.32 billion, RMB3.96 billion, and RMB4.77 billion in 2025-2027, representing...","market":"fut","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK0096","BK0187","600196","BK0175","BK0183","161027","BK0060","BK0012","BK1515","BK0239","BK1593","02196","BK0188","BK0196","BK1191","BK0028"],"gpt_icon":0},{"id":"1156221278","title":"Chinese Automakers Achieve Best Month in Europe, Market Share Surpasses Korean Rivals for First Time","url":"https://stock-news.laohu8.com/highlight/detail?id=1156221278","media":"Deep News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1156221278?lang=en_us&edition=fundamental","pubTime":"2025-10-29 14:36","pubTimestamp":1761719801,"startTime":"0","endTime":"0","summary":"Chinese automakers have recorded their strongest performance to date in the European market, driven by robust growth in pure electric and hybrid vehicle segments. According to research firm...","market":"fut","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU1880383366.USD","LU2348774022.SGD","LU1064130708.USD","LU0314109678.HKD","LU2357125470.USD","LU2449936058.SGD","BK1149","BK1539","BK1540","LU0244354667.USD","LU0505663152.USD","LU0516422366.SGD","LU1023057109.AUD","BK0196","LU0143863198.USD","LU0823426308.USD","BK1589","LU0823039010.USD","LU2476274720.SGD","LU0289961442.SGD","BK0155","LU2289578879.USD","LU0828238088.HKD","LU0165289439.USD","LU1303224171.USD","LU0823038988.USD","LU0359201612.USD","LU0164865239.USD","LU0531970944.HKD","LU2476274308.USD","BK1594","LU0417516738.SGD","LU1861219969.SGD","LU1969619763.USD","LU2249611893.SGD","BK0014","BK1522","LU0593848301.USD","LU2097828805.USD","LU1868837565.USD","LU0588545490.SGD","SG9999006597.SGD","LU0143863784.USD","LU0633140727.USD","LU1781817850.SGD","LU0511384066.AUD","LU0543330566.HKD","81211","LU0175139822.USD","LU2580892862.HKD","LU0039217434.USD","LU0516422952.EUR","LU0417516902.SGD","SG9999001226.SGD","LU1880383440.USD","LU1997244956.HKD","LU1961090484.USD","LU2097828474.EUR","LU0588545904.SGD","BK1582","LU1242518857.USD","LU0254981946.USD","LU0823414478.USD","LU1242518931.SGD","LU1251922891.USD","LU0509642566.USD","LU0683595622.HKD","BK0169","LU1794554557.SGD","LU1146622755.USD","BK1610","LU0054450605.USD","BK1607","LU1861214812.USD","BK0264","LU0561508036.HKD","LU1813983027.USD","LU1868838027.USD","LU0819123356.HKD","LU0348825331.USD","BK0072","01211","LU0463099449.HKD","LU0164872284.USD","LU1997245177.USD","LU0605514214.HKD","LU0084288322.USD","LU0359201885.HKD","LU0307460666.USD","LU2495084118.USD","SG9999014674.SGD","LU2360107325.USD","LU0348735423.USD","LU1770034418.SGD","SG9999006514.SGD","LU0348766576.USD","LU2506951792.HKD","LU0572944931.SGD","LU0348767384.USD","LU0229945570.USD","LU0289960550.SGD","LU0865486749.SGD","LU1868837722.USD","BK1504","LU0214875030.USD","00285","LU0320764599.SGD","LU0540923850.HKD","LU0315178854.USD","LU2663582299.SGD","LU2399975544.HKD","SG9999015978.USD","LU0594300419.USD","LU0449509016.USD","LU0588545730.USD","LU1508157978.USD","LU0516423091.SGD","LU0708995583.HKD","002594","LU0274383008.USD","LU0979878070.USD","LU1328277881.USD","LU2097828714.EUR","LU0043850808.USD","SG9999015952.SGD","LU2294711713.HKD","LU0289739343.SGD","LU0588546209.SGD","LU2097828631.EUR","LU1580142542.USD","LU0531971595.HKD","IE00BD6J9T35.USD","LU0348827113.USD","LU0823414551.USD","LU0516422440.USD","LU2580892789.USD","LU0326950275.SGD","EVS.SI","LU0633140560.USD","LU2153592121.USD","BK1515","LU2148510915.USD","LU1064131003.USD","LU0516423174.USD","LU2778985437.USD","LU0650527681.SGD","BK0188","BK0183","LU2039709279.SGD","LU1820825898.SGD","LU0469268626.HKD","BK1119","LU1720050803.USD","LU0823426480.USD","BK1580","LU0259732245.USD","BK1509","LU0634319403.HKD","LU0594300179.USD","LU0449515922.USD","LU0871576103.HKD","LU0819121731.USD","LU2328871848.SGD","SG9999015945.SGD","LU0348805143.USD","SG9999015986.USD","LU1719994722.HKD","BYDDY","LU0327786744.USD","LU0211977185.USD","SG9999002828.SGD","LU1188198961.HKD","SG9999002463.SGD","LU0856984785.SGD","LU0052750758.USD","LU0359202008.SGD","BK0070","HYDD.SI","LU1808992512.USD","LU0269904917.USD","LU1997245094.SGD","LU2097828557.USD"],"gpt_icon":1},{"id":"1195466306","title":"Jilin Explores New \"Group Elderly Care\" Model Through Shared Village Communities","url":"https://stock-news.laohu8.com/highlight/detail?id=1195466306","media":"Deep News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1195466306?lang=en_us&edition=fundamental","pubTime":"2025-10-29 10:31","pubTimestamp":1761705114,"startTime":"0","endTime":"0","summary":"The 2025 government work report emphasized advancing community-supported home-based elderly care, strengthening care for disabled seniors, expanding meal assistance, rehabilitation equipment support,...","market":"other","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1189","BK1589","BK1615","00241","BK1501","BK1515","BK1617","BK1247","BK1591","BK1610","BK1142","BK1584","BK1502","BK1571"],"gpt_icon":0},{"id":"1142134699","title":"CICC Maintains Outperform Rating on SINOPHARM (01099) with Target Price of HK$24.7","url":"https://stock-news.laohu8.com/highlight/detail?id=1142134699","media":"Stock News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1142134699?lang=en_us&edition=fundamental","pubTime":"2025-10-29 10:18","pubTimestamp":1761704302,"startTime":"0","endTime":"0","summary":"CICC has reiterated its 2025/2026 net profit forecasts for SINOPHARM (01099) at RMB 7.475 billion and RMB 7.926 billion, representing year-on-year growth of 6.0% each. The current share price implies...","market":"nz","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0640798160.USD","BK1515","LU1115378108.SGD","BK1500","01099","BK1197"],"gpt_icon":0},{"id":"1140599212","title":"Puyin International Maintains \"Hold\" Rating on PA GOODDOCTOR (01833) with Target Price of HK$14.0","url":"https://stock-news.laohu8.com/highlight/detail?id=1140599212","media":"Stock News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1140599212?lang=en_us&edition=fundamental","pubTime":"2025-10-29 09:46","pubTimestamp":1761702396,"startTime":"0","endTime":"0","summary":"Puyin International released a research report stating that PA GOODDOCTOR (01833) demonstrated steady growth in revenue and net profit in 3Q25, with full-year revenue expected to increase by...","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1615","01833","BK1571","BK1219","BK1515","BK1247","BK1142","BK1617"],"gpt_icon":0},{"id":"1143902260","title":"HK Stock Buyback Summary | October 29","url":"https://stock-news.laohu8.com/highlight/detail?id=1143902260","media":"Stock News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1143902260?lang=en_us&edition=fundamental","pubTime":"2025-10-29 09:12","pubTimestamp":1761700355,"startTime":"0","endTime":"0","summary":"On October 28, 2025, multiple companies conducted share buybacks in the Hong Kong stock market. Among them, China Feihe (06186) recorded the highest buyback amount, repurchasing 5.174 million shares...","market":"sg","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["08128","02319","BK1202","09890","BK1583","LU0173614495.USD","LU0163747925.USD","02373","LU0823426480.USD","HK0000320223.HKD","BK1170","LU0359201612.USD","09966","01866","01583","IE00B031J352.USD","LU0029875118.USD","HK0000320264.USD","LU0211977185.USD","LU0672654166.SGD","LU0370786039.SGD","BK1519","BK1526","LU1102505929.USD","LU0072462343.USD","BK1151","BK1258","IE00B0169L03.USD","02273","BK1225","IE00B031HY20.USD","BK1500","BK1160","LU0588546209.SGD","06826","BK1597","LU0328353924.USD","BK1606","00947","BK1516","IE0008369823.USD","LU0315179316.USD","LU0307460666.USD","BK1521","BK1191","02869","LU0543330483.HKD","LU0320764755.SGD","BK1619","BK1574","BK1587","LU0348788117.USD","00732","LU0259732245.USD","BK1201","LU0385154629.USD","LU1439103000.SGD","BK1553","01497","BK1113","BK1543","LU1048588211.SGD","LU0651946864.USD","BK1599","BK1549","BK1253","02299","LU0048580855.USD","01681","00777","LU0287142896.SGD","01586","BK1161","LU0737861699.HKD","00103","BK1155","SG9999002828.SGD","LU0251143458.SGD","00418","LU1023057109.AUD","BK1158","06868","LU0594300419.USD","LU1224709979.USD","LU0359202008.SGD","BK1506","BK1219","LU0650527681.SGD","LU0326950275.SGD","IE0008368742.USD","BK1149","BK1589","BK1575","LU0359201885.HKD","02190","HK0000306685.HKD","BK1531","IE0009570106.USD","IE0031814852.USD","BK1104","BK1215","IE0032834883.USD","IE00B29SXG58.USD","LU1102505762.USD","BK1593","LU0106959298.USD","BK1100","LU0471298777.SGD","BK1229","BK1542","SG9999011746.SGD","01373","02598","IE00B97KM107.HKD","LU1051768304.USD","01519","06186","01672","LU0228367735.SGD","LU2125910500.SGD","02486","LU0128522157.USD","LU2045819591.USD","LU0228659784.USD","09959","BK1137","LU1769817096.USD","BK1109","LU1515016050.SGD","BK1237","LU1769817179.HKD","02416","IE00B067MR52.USD","BK1518","HK0000306701.USD","LU0823426308.USD","BK1515"],"gpt_icon":0},{"id":"2578393296","title":"BRIEF-Tong Ren Tang Technologies Says 9M Unaudited Net Profits Attributable RMB416.26 Million","url":"https://stock-news.laohu8.com/highlight/detail?id=2578393296","media":"Reuters","labels":["dataReport","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2578393296?lang=en_us&edition=fundamental","pubTime":"2025-10-28 18:25","pubTimestamp":1761647141,"startTime":"0","endTime":"0","summary":"BRIEF-Tong Ren Tang Technologies Says 9M Unaudited Net Profits Attributable RMB416.26 MillionOct 28  - Tong Ren Tang Technologies Co Ltd 1666.HK:9M UNAUDITED NET PROFITS ATTRIBUTABLE RMB416.26 MILLION9M OPERATING REVENUE OF ABOUT RMB4,979.64 MILLIONFurther company coverage: 1666.HK ","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251028:nFWN3W90CN:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"dataReport,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["01666","BK1606","BK1515","BK1191","BK1583"],"gpt_icon":0},{"id":"1195799752","title":"BAIYUNSHAN PH (00874) Reports Q3 Results: Net Profit Rises 4.78% YoY to RMB3.31 Billion","url":"https://stock-news.laohu8.com/highlight/detail?id=1195799752","media":"Stock News","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1195799752?lang=en_us&edition=fundamental","pubTime":"2025-10-28 18:16","pubTimestamp":1761646587,"startTime":"0","endTime":"0","summary":"BAIYUNSHAN PH (00874) announced its financial results for the first three quarters of 2025. The group achieved operating revenue of RMB61.606 billion, representing a year-on-year increase of 4.31%....","market":"sg","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1521","BK0196","BK1197","BK0070","BK0097","BK0188","BK1606","BK0175","BK1515","00874","600332","BK1191","BK0012","BK0096","BK0239","BK0183","BK0028"],"gpt_icon":0},{"id":"1120081862","title":"ASCLETIS-B (01672) Repurchased 100,000 Shares for HK$918,900 on October 28","url":"https://stock-news.laohu8.com/highlight/detail?id=1120081862","media":"Stock News","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1120081862?lang=en_us&edition=fundamental","pubTime":"2025-10-28 17:50","pubTimestamp":1761645046,"startTime":"0","endTime":"0","summary":"ASCLETIS-B (01672) announced that on October 28, 2025, the company repurchased 100,000 shares at a price range of HK$9.14 to HK$9.31 per share, totaling HK$918,900.","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1515","BK1574","BK1191","BK1161","01672","01477"],"gpt_icon":0}],"pageSize":20,"totalPage":10,"pageCount":3,"totalSize":197,"code":"91000000","status":"200"}]}}